2023 World Conference on Lung Cancer (Posters)-EP17.04. Global, Regional, National Burden of Lung Cancer Attributable to High Fasting Plasma Glucose

EP17.04. Global, Regional, National Burden of Lung Cancer Attributable to High Fasting Plasma Glucose - PDF(Abstract)

Pdf Summary

This study evaluated the global burden of lung cancer attributable to high fasting plasma glucose (HFPG). The researchers retrieved data on deaths and disability-adjusted life-years related to HFPG in 204 countries and territories from 1990 to 2019. They found that in 2019, HFPG caused 179,048 lung cancer deaths, with an age-standardized death rate of 2.22 per 100,000 population. The burden of lung cancer attributable to HFPG increased over the study period, with regions of higher development levels experiencing a heavier burden. The burden of disease also varied by age group, with the highest burden in the 65-69 age group. Men in high-development countries were found to have a higher burden of lung cancer attributable to HFPG compared to women. However, the burden in women showed a rapidly increasing trend in all regions. The study highlights the need to pay attention to the burden of lung cancer attributable to metabolic disorders, with a focus on men in high-development countries and the 65-69 age group. The increasing trend in women should also be a cause for concern.

Asset Subtitle

Minmin Wang

Meta Tag

Speaker Minmin Wang

Topic Global Health, Health Services & Health Economics: Real World Data

Keywords

lung cancer

high fasting plasma glucose

HFPG

global burden

deaths

disability-adjusted life-years

age-standardized death rate

development levels

age group

metabolic disorders